Interventions on residual lesions in patients with heterotaxy syndrome following orthotropic heart transplantation: A single‐center experience

Abstract

AbstractBackgroundHeterotaxy syndrome (HS) is a defect in lateralization which often results in complex intra and extracardiac abnormalities. Orthotropic heart transplantation (OHT) in HS involves intricate and individualized modifications to surgical technique. Post‐OHT outcomes are worse in patients with HS, however, the impact of post‐OHT residual lesions has not yet been characterized.MethodsPatients with HS who underwent OHT at Ann & Robert H. Lurie Children's Hospital of Chicago between January 2012 and June 2023 were identified. Patients were excluded if follow‐up data was not available due to follow up at a different institution of early mortality. Pre‐OHT clinical data, surgical data, and post‐OHT surgical and catheterization data were collected.ResultsTwo early mortalities were excluded from analysis, leaving 15 patients in the study cohort. Median age at OHT was 3.7 years (range: 0.7–15.4). Nine out of 15 patients were diagnosed with residual lesions requiring intervention at a median of 188 days post transplantation. All interventions on residual lesions occurred via catheterization. Overall mortality rate was 27% (4/15) with all deaths occurring in patients with residual lesions (4/9 patients, 44%). 83% (10/12) of lesions were diagnosed via catheterization, and 83% (10/12) of lesions of occurred in the first year after transplant.ConclusionsPatients with HS are at high risk for residual lesions after OHT, which may contribute to increased mortality. Comprehensive invasive diagnostics were required to diagnose residual lesions, which were all addressed percutaneously.